{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T20:40:52Z","timestamp":1794429652111,"version":"4.9.1"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Large tumor size is associated with poor outcomes in patients with hepatocellular carcinoma (HCC). Although some studies have evaluated the treatment response of HCC to transarterial radioembolization (TARE), none of them used radiomics features with machine learning (ML) models in large tumors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>To assess the performance of ML models using radiomics to predict the treatment response of TARE in large HCC lesions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This study included 49 patients with a large (&gt;5 cm) HCC who underwent TARE. Treatment response was determined according to modified response evaluation criteria in solid tumors (mRECIST) criteria from the 3-month follow-up MR examinations. Complete or partial response was categorized as the responder group, while stable or progressive disease was classified as the non-responder group. Segmentation was performed on axial T2-weighted (T2W) and contrast-enhanced (CE) T1-weighted images. Classification learning models were used to create prediction models for TARE response.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Forty-nine patients (9 female, 40 male; mean age 63.58 \u00b1 8.77) were included. None of the clinical, laboratory, and radiologic characteristics except the neutrophil counts showed statistical significance. Radiomics models obtained from CE-T1 and T2W images demonstrated an accuracy rate of 79.6%, while the area under the curve (AUC) rates were 0.92 and 0.77, respectively. The clinical model showed an accuracy rate of 77.6% and an AUC of 0.65. No statistically significant difference was found among all the models (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.092).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>ML-based models constructed with radiomics features obtained from MR images before the TARE procedure might predict response in large HCC lesions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/njcp.njcp_305_25","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T17:00:12Z","timestamp":1758992412000},"page":"1111-1120","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Machine Learning using MR \u0130maging Radiomics can Predict the Response of Large Hepatocellular Carcinoma to Transarterial Radioembolization"],"prefix":"10.4103","volume":"28","author":[{"given":"O","family":"Sarioglu","sequence":"first","affiliation":[{"name":"Department of Radiology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Canturk","sequence":"additional","affiliation":[{"name":"Department of Radiology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RC","family":"Yarol","sequence":"additional","affiliation":[{"name":"Department of Radiology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Gulmez","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, \u0130zmir Democracy University, Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FC","family":"Sarioglu","sequence":"additional","affiliation":[{"name":"Department of Radiology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Derebek","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Gulcu","sequence":"additional","affiliation":[{"name":"Department of Radiology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,27]]},"reference":[{"key":"R1-20260420","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/hep.29691","article-title":"Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience","volume":"68","author":"Salem","year":"2018","journal-title":"Hepatology"},{"key":"R2-20260420","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J Hepatol"},{"key":"R3-20260420","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s00270-009-9728-y","article-title":"MDCT versus MRI assessment of tumor response after transarterial chemoembolization for the treatment of hepatocellular carcinoma","volume":"33","author":"Kloeckner","year":"2010","journal-title":"Cardiovasc Intervent Radiol"},{"key":"R4-20260420","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/lt.20472","article-title":"Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma","volume":"11","author":"Pawlik","year":"2005","journal-title":"Liver Transpl"},{"key":"R5-20260420","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.amjsurg.2008.09.019","article-title":"Outcome after curative resection for a huge (>or=10 cm) hepatocellular carcinoma and prognostic significance of gross tumor classification","volume":"198","author":"Choi","year":"2009","journal-title":"Am J Surg"},{"key":"R6-20260420","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.2147\/CMAR.S251413","article-title":"development and validation of pre- and post-operative models to predict recurrence after resection of solitary hepatocellular carcinoma: A multi-\u0131nstitutional study","volume":"15","author":"Wu","year":"2020","journal-title":"Cancer Manag Res"},{"key":"R7-20260420","first-page":"9264137","article-title":"A nomogram predicting microvascular \u0131nvasion risk in BCLC 0\/A hepatocellular carcinoma after curative resection","volume":"25","author":"Gao","year":"2019","journal-title":"Biomed Res Int"},{"key":"R8-20260420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jvir.2018.07.002","article-title":"Feasibility of boosted radioembolization for hepatocellular carcinoma larger than 5 cm","volume":"30","author":"Kim","year":"2019","journal-title":"J Vasc Interv Radiol"},{"key":"R9-20260420","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","article-title":"Radiomics: The bridge between medical imaging and personalized medicine","volume":"14","author":"Lambin","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"R10-20260420","doi-asserted-by":"crossref","first-page":"13248","DOI":"10.18632\/oncotarget.7467","article-title":"Computed tomography texture analysis to facilitate therapeutic decision making in hepatocellular carcinoma","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"R11-20260420","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.18632\/oncotarget.23423","article-title":"Signature of survival: A 18F-FDG PET based whole-liver radiomic analysis predicts survival after 90Y-TARE for hepatocellular carcinoma","volume":"9","author":"Blanc-Durand","year":"2017","journal-title":"Oncotarget"},{"key":"R12-20260420","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.jvir.2023.06.023","article-title":"Early prediction of response of hepatocellular carcinoma to yttrium-90 radiation segmentectomy using a machine learning MR \u0131maging radiomic approach","volume":"34","author":"Marinelli","year":"2023","journal-title":"J Vasc Interv Radiol"},{"key":"R13-20260420","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jvir.2022.11.004","article-title":"Prediction of response of hepatocellular carcinoma to radioembolization: Machine learning using preprocedural clinical factors and MR \u0131maging radiomics","volume":"34","author":"\u0130nce","year":"2023","journal-title":"J Vasc Interv Radiol"},{"key":"R14-20260420","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"key":"R15-20260420","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1158\/0008-5472.CAN-18-0125","article-title":"LIFEx: A freeware for radiomic feature calculation in multimodality \u0131maging to accelerate advances in the characterization of tumor heterogeneity","volume":"78","author":"Nioche","year":"2018","journal-title":"Cancer Res"},{"key":"R16-20260420","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.mri.2003.09.001","article-title":"Influence of MRI acquisition protocols and image intensity normalization methods on texture classification","volume":"22","author":"Collewet","year":"2004","journal-title":"Magn Reson Imaging"},{"key":"R17-20260420","first-page":"100046","article-title":"Assessment of a multivariable model using MRI-radiomics, age and sex for the classification of hepatocellular adenoma subtypes","volume":"5","author":"Declaux","year":"2024","journal-title":"Res Diagn Interv Imaging"},{"key":"R18-20260420","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13244-023-01572-w","article-title":"METhodological RadiomICs Score (METRICS): A quality scoring tool for radiomics research endorsed by EuSoMII","volume":"15","author":"Kocak","year":"2024","journal-title":"Insights Imaging"},{"key":"R19-20260420","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/SLA.0000000000006061","article-title":"Resection postradioembolization in patients with single large hepatocellular carcinoma","volume":"278","author":"Tzedakis","year":"2023","journal-title":"Ann Surg"},{"key":"R20-20260420","doi-asserted-by":"crossref","first-page":"351","DOI":"10.21037\/hbsn-22-184","article-title":"Large, multifocal or portal vein-invading hepatocellular carcinoma (HCC) downstaged by Y90 using personalized dosimetry: Safety, pathological results and outcomes after surgery","volume":"12","author":"Meerun","year":"2023","journal-title":"Hepatobiliary Surg Nutr"},{"key":"R21-20260420","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.diii.2022.01.009","article-title":"Comparison of MRI-based response criteria and radiomics for the prediction of early response to transarterial radioembolization in patients with hepatocellular carcinoma","volume":"103","author":"Aujay","year":"2022","journal-title":"Diagn Interv Imaging"},{"key":"R22-20260420","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jacr.2023.12.029","article-title":"Radiomics features extracted from pre- and postprocedural \u0131maging in early prediction of treatment response in patients undergoing transarterial radioembolization of hepatic lesions: A systematic review, meta-analysis, and quality appraisal study","volume":"21","author":"Mirza-Aghazadeh-Attari","year":"2024","journal-title":"J Am Coll Radiol"},{"key":"R23-20260420","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/MNM.0000000000001572","article-title":"The role of volumetric and textural analysis of pretreatment 18F-fluorodeoxyglucose PET\/computerized tomography images in predicting complete response to transarterial radioembolization in hepatocellular cancer","volume":"43","author":"Karahan \u015een","year":"2022","journal-title":"Nucl Med Commun"},{"key":"R24-20260420","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40658-020-00340-9","article-title":"Tumor response prediction in 90Y radioembolization with PET-based radiomics features and absorbed dose metrics","volume":"7","author":"Wei","year":"2020","journal-title":"EJNMMI Phys"},{"key":"R25-20260420","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.3390\/ijms23073636","article-title":"Neutrophil to lymphocyte ratio: An emerging marker of the relationships between the \u0131mmune system and diseases","volume":"23","author":"Buonacera","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R26-20260420","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1002\/hep4.2072","article-title":"Hepatic decompensation after transarterial radioembolization: A retrospective analysis of risk factors and outcome in patients with hepatocellular carcinoma","volume":"6","author":"Reincke","year":"2022","journal-title":"Hepatol Commun"},{"key":"R27-20260420","doi-asserted-by":"crossref","first-page":"72343","DOI":"10.18632\/oncotarget.11644","article-title":"Trans-arterial radioembolization in intermediate-advanced hepatocellular carcinoma: Systematic review and meta-analyses","volume":"7","author":"Rognoni","year":"2016","journal-title":"Oncotarget"},{"key":"R28-20260420","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1148\/rg.2019180095","article-title":"Expected and unexpected \u0131maging findings after 90Y transarterial radioembolization for liver tumors","volume":"39","author":"Spina","year":"2019","journal-title":"Radiographics"}],"container-title":["Nigerian Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_305_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:47:30Z","timestamp":1787068050000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_305_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/njcp.njcp_305_25","relation":{},"ISSN":["1119-3077","2229-7731"],"issn-type":[{"value":"1119-3077","type":"print"},{"value":"2229-7731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"2025-05-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}